3.68
Polypid Ltd Borsa (PYPD) Ultime notizie
Is PolyPid Ltd. a good long term investmentExceptional earning trajectories - PrintWeekIndia
Is PolyPid Ltd. stock a good hedge against inflationFree Stock Selection - jammulinksnews.com
Will PolyPid Ltd. stock benefit from interest rate changesRapid wealth multiplication - jammulinksnews.com
Why PolyPid Ltd. stock attracts strong analyst attentionReal Trader Insights - Newser
PolyPid Ltd. Stock Analysis and ForecastConsistently exceptional gains - Autocar Professional
What analysts say about PolyPid Ltd. stockUnmatched profit growth - jammulinksnews.com
What drives PolyPid Ltd. stock priceConsistent high-yield stocks - Autocar Professional
PolyPid Launches Long-Acting GLP-1 Delivery Platform for Diabetes Market - The Globe and Mail
PYPD: Positive Topline Data From D-PLEX₁₀₀ Trial Contributes to Multiple Subsequent Benefits - Yahoo Finance
PolyPid's Game-Changing 60-Day GLP-1 Platform Could Disrupt $100B Weight Loss Market - openPR.com
How PolyPid Ltd. stock performs during market volatilityFree Exclusive Stock Market Insights - Newser
What makes PolyPid Ltd. stock price move sharplyFree Exclusive Stock Market Insights - Newser
Analysts Set PolyPid Ltd. (NASDAQ:PYPD) Price Target at $11.80 - Defense World
Finance Herald Publishes Coverage of PolyPid's Groundbreaking New 60-Day GLP-1 Delivery Tech - The Manila Times
PolyPid unveils 60-day GLP-1 delivery platform for diabetes treatment - Investing.com Australia
PolyPid Unveils a Long-Acting GLP-1 Receptor Agonists - GlobeNewswire
Revolutionary 60-Day GLP-1 Injection Could Replace Weekly Diabetes Treatments, PolyPid Announces - Stock Titan
PolyPid (NASDAQ:PYPD) Raised to “Hold” at Wall Street Zen - Defense World
PolyPid (NASDAQ:PYPD) Stock Price Down 0.6% – Here’s What Happened - Defense World
Is PolyPid Stock Undervalued? (NASDAQ: PYPD) - newsblaze.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):